Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging
- 1 November 2003
- journal article
- Published by Elsevier in Academic Radiology
- Vol. 10 (11) , 1237-1246
- https://doi.org/10.1016/s1076-6332(03)00248-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Macromolecular contrast agents for MR mammography: current statusEuropean Radiology, 2003
- MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast CancerRadiology, 2001
- International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesionsEuropean Radiology, 2001
- In vivo monitoring of tumor angiogenesis with MR imagingAcademic Radiology, 2000
- Dynamic Breast MR Imaging: Are Signal Intensity Time Course Data Useful for Differential Diagnosis of Enhancing Lesions?Radiology, 1999
- Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.American Journal of Roentgenology, 1998
- Physiologic measurements by contrast‐enhanced MR imaging: Expectations and limitationsJournal of Magnetic Resonance Imaging, 1997
- Quantification of Capillary Permeability to Macromolecular Magnetic Resonance Imaging Contrast Media in Experimental Mammary AdenocarcinomasInvestigative Radiology, 1994
- Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.Radiology, 1994
- Vascular and interstitial barriers to delivery of therapeutic agents in tumorsCancer and Metastasis Reviews, 1990